Navigation Links
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Date:10/19/2009

EAST HANOVER, N.J., Oct. 20 /PRNewswire/ -- Novartis announced today that Tasigna® (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec® (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study (5,6).

The Phase III clinical trial, Evaluating Nilotinib Efficacy and Safety in Clinical Trials of Newly Diagnosed Ph+ CML Patients (ENESTnd), is the largest global randomized comparison of two oral therapies ever conducted in newly diagnosed Ph+ CML patients. Designed to detect a difference in major molecular response (MMR) between Tasigna and Gleevec after 12 months of treatment, it is also the first registration study in which molecular traces of a key biomarker specific to Ph+ CML have been used as a primary endpoint for regulatory review. The comparison study also met its secondary endpoint, a difference in complete cytogenetic response (CCyR) in favor of Tasigna (5,6).

"We developed Tasigna to be a potent and selective inhibitor of Bcr-Abl, with the goal of eliminating the underlying cause of Ph+ CML. We now know that Tasigna reduces the level of Bcr-Abl faster and to a lower level than Gleevec, with profound implications for improving patients' outcomes," said David Epstein, President and CEO of Novartis Oncology and Novartis Molecular Diagnostics. "Molecular monitoring enables us to evaluate whether patients have achieved this deep level of CML residual disease, reducing the fundamental biomarker of leukemia to nearly undetectable levels."

The blood test used to determine molecular response can detect a single cell containing traces of Bcr-Abl in up to one mil
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
2. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
3. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
4. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
5. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
8. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
9. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 ... Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, ... Growth, Trends and Forecast, 2013-2019" the global endoscopy devices ... and is expected to grow at a CAGR of ... value of USD 36.9 billion in 2019. ...
(Date:7/11/2014)... , July 11, 2014 ... visitors to Safety & Health Expo 2014 ... the move to London ... management attending exhibition.     ... http://photos.prnewswire.com/prnh/20140711/696892-a )      ...
(Date:7/10/2014)... NEWS, Virginia , 11. Juli ... Hersteller von Kameras für die molekulare ... (MBI/BSGI), hat heute die CE-Zulassung für ... dem CE-Zeichen kann Dilon das Produkt ... Vertriebsbereich auf den Großteil der europäischen ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2
... NATICK, Mass., March 29, 2011 Boston Scientific Corporation ... trial news and events schedule at the 60th Annual ... April 2-5, 2011 in New Orleans. "Twelve-month ... important data on our next-generation PROMUS Element™ Everolimus-Eluting Platinum ...
... 2011 Tris Pharma, Inc., a specialty pharmaceutical company, ... Iron product line.  Since the 2007 launch ... of pediatricians, pediatric nurses and mothers.  When the previous ... different direction, availability of MyKidz Iron™ became limited, but ...
Cached Medicine Technology:Boston Scientific Announces Its ACC 2011 Schedule 2Boston Scientific Announces Its ACC 2011 Schedule 3Boston Scientific Announces Its ACC 2011 Schedule 4Boston Scientific Announces Its ACC 2011 Schedule 5Boston Scientific Announces Its ACC 2011 Schedule 6Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements 2Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements 3
(Date:7/11/2014)... (PRWEB) July 11, 2014 Fadhits.com, the ... its elegant assortment of lace holiday dresses . ... products are now offered at discounted prices, up to ... website can enjoy this special offer. , Fadhits.com ... and special occasion dresses for the global clients. All ...
(Date:7/11/2014)... 2014 Bedros Keuilian is known in fitness ... earned by founding the fast-selling fitness franchise in the country ... He works with successful boot camp owners on a daily ... traits of the most successful boot camp owners , he ... , “I’ve worked with and coached some of the most ...
(Date:7/11/2014)... As reported by Forbes in the ... Genetics To Blame (6/30), Indino Downey has reportedly been ... to smoke it with. His father, well-known actor Robert ... inherited from him may have something to do with ... during the 1980s and 1990s for substance abuse before ...
(Date:7/11/2014)... Australia (PRWEB) July 11, 2014 ... organic food being launched into the limelight over the ... “Although it was once considered to be an alternative ... of consumers are now purchasing organic food.” Organic crop ... organic fruits, vegetables, grains, nuts and herbs over the ...
(Date:7/11/2014)... -- A new study challenges the widely held belief that ... Researchers analyzed more than 50 studies that examined drinking ... They found that those with a form of a gene ... The gene affects how a person,s body breaks down alcohol, ... Having this variant has been shown to lead to lower ...
Breaking Medicine News(10 mins):Health News:Elegant Lace Holiday Dresses Released by Fadhits.com 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 2Health News:Fitness Boot Camp Marketing Expert Bedros Keuilian Shares the Top Three Traits of Successful Boot Camp Owners 3Health News:Roberty Downey's Son Arrested For Cocaine 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:A Little Alcohol May Not Be Good for Your Heart After All 2
... ... grupos de socorro a que tengan en cuenta las necesidades especiales , ... Washington, D.C.(Vocus) January 24, 2010 ... y los niños en Haití no estén recibiendo una proporción justa de la enorme ...
... or ambidextrous, are more likely to have mental health, ... left-handed children, according to a new study published today ... researchers behind the study, from Imperial College London and ... teachers and health professionals to identify children who are ...
... SALT LAKE CITY, Jan. 24, 2010 When University of ... generated by an electrically conducting plastic or polymer, no one ... real. Now, a decade later, the Utah researchers have found ... the polymers, and they say such lasers may prove useful ...
... , ... Company establishes an Employee Stock Ownership Plan , ... Charlotte, NC(PRWEB) January 24, 2010 -- ORCS Web Inc., ... worldwide with managed hosting solutions, announced the establishment of an Employee Stock Ownership Plan ...
... ... lead to new treatments for millions of women suffering from fibroid tumors , ... Nashville, TN (Vocus) January 22, 2010 -- ... used as a treatment for uterine fibroids, a disease that affects forty percent of reproductive ...
... ... and healthcare facilities forced to cut costs and limit expenditures or face closures, increasingly ... spend management and real-time budgeting applications to help monitor and control their outside legal ... ...
Cached Medicine News:Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 2Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 3Health News:Estn las Mujeres y los Nios de Hait Recibiendo Menos Ayuda Tras el Terremoto? 4Health News:Mixed-handed children more likely to have mental health, language and scholastic problems 2Health News:Mixed-handed children more likely to have mental health, language and scholastic problems 3Health News:How 'random' lasers work 2Health News:How 'random' lasers work 3Health News:How 'random' lasers work 4Health News:How 'random' lasers work 5Health News:ORCS Web, Inc Announces Plans for Employee Ownership 2Health News:Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids, 2Health News:doeLegal's doeBilling™ Allows Bayhealth Medical to “Regain Control” of Outside Vendor Legal Spend 2Health News:doeLegal's doeBilling™ Allows Bayhealth Medical to “Regain Control” of Outside Vendor Legal Spend 3Health News:doeLegal's doeBilling™ Allows Bayhealth Medical to “Regain Control” of Outside Vendor Legal Spend 4
Idophor PVP Scrub Winged Sponges...
Triad Plus PVP-I Scrub Winged Sponges...
... preoperative skin preparation an ... site infections. Scrub Care brand ... offer high efficacy and safety ... Prevail-Fx offers the highest level ...
Single-dose applicator. Provides a superior, hands-off "friction scrub," enhancing the efficacy of the antiseptic solution it delivers....
Medicine Products: